Ashwagandha is projected to account for 39.4% of Adaptogen demand in 2026, while Stress Balance is expected to represent 33.9% of Function demand. Citrus is forecast at 27.9% of Flavor demand, Wellness Enthusiasts at 30.7% of End User demand, and Supermarkets & Hypermarkets at 50.8% of Sales Channel demand. Commercial adoption depends on credible hydration performance and acceptable taste, while botanical safety and claim requirements shape formulation choices across countries.